Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cantor Fitzgerald
Healthtrust
Chinese Patent Office
Argus Health
Fish and Richardson
Boehringer Ingelheim
Julphar
Federal Trade Commission

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TRIAMCINOLONE HEXACETONIDE

« Back to Dashboard

Clinical Trials for Triamcinolone Hexacetonide

Trial ID Title Status Sponsor Phase Summary
NCT00506896 Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients Completed Federal University of São Paulo Phase 2 The purpose of this study is to compare the efficacy and safety of intra-articular glucocorticoid injection to its systemic use for treatment of knee synovitis in patients with Rheumatoid Arthritis
NCT00588354 Epidural Clonidine for Lumbosacral Radiculopathy Terminated National Center for Research Resources (NCRR) N/A This was a randomized, blinded study of transforaminal epidural injection of clonidine versus a similar injection of corticosteroid for acute lumbosacral radiculopathy. The hypothesis was that clonidine will be as effective as steroid for this condition.
NCT00588354 Epidural Clonidine for Lumbosacral Radiculopathy Terminated Mayo Clinic N/A This was a randomized, blinded study of transforaminal epidural injection of clonidine versus a similar injection of corticosteroid for acute lumbosacral radiculopathy. The hypothesis was that clonidine will be as effective as steroid for this condition.
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Completed Aarhus University Hospital Phase 3 Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis. A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development. Optimized Treatment Algorithms for Patients with Early RA
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Completed Abbott Phase 3 Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis. A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development. Optimized Treatment Algorithms for Patients with Early RA
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Completed Meda Pharmaceuticals Phase 3 Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis. A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development. Optimized Treatment Algorithms for Patients with Early RA
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Triamcinolone Hexacetonide

Condition Name

Condition Name for Triamcinolone Hexacetonide
Intervention Trials
Rheumatoid Arthritis 2
Osteoarthritis 2
Adhesive Capsulitis 1
Legg-Calve Perthes Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Triamcinolone Hexacetonide
Intervention Trials
Osteoarthritis 5
Arthritis 4
Arthritis, Rheumatoid 3
Osteoarthritis, Knee 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Triamcinolone Hexacetonide

Trials by Country

Trials by Country for Triamcinolone Hexacetonide
Location Trials
Brazil 6
United States 4
Norway 1
Denmark 1
Hungary 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Triamcinolone Hexacetonide
Location Trials
Wisconsin 1
Florida 1
Washington 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Triamcinolone Hexacetonide

Clinical Trial Phase

Clinical Trial Phase for Triamcinolone Hexacetonide
Clinical Trial Phase Trials
Phase 4 5
Phase 3 2
Phase 2 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Triamcinolone Hexacetonide
Clinical Trial Phase Trials
Completed 6
Recruiting 5
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Triamcinolone Hexacetonide

Sponsor Name

Sponsor Name for Triamcinolone Hexacetonide
Sponsor Trials
Federal University of São Paulo 4
University of Sao Paulo General Hospital 2
Fundação de Amparo à Pesquisa do Estado de São Paulo 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Triamcinolone Hexacetonide
Sponsor Trials
Other 16
Industry 4
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
McKinsey
US Army
Cantor Fitzgerald
Healthtrust
Deloitte
Merck
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.